| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |